Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.USPTO Issues New Patent To Ryogen
Ryogen has been awarded a new patent titled ‘Isolated Genomic Polynucleotide Fragments from Chromosome 7’. US patent No 7588915 has been issued by the US Patent and Trademark
Ryogen has been awarded a new patent titled ‘Isolated Genomic Polynucleotide Fragments from Chromosome 7’. US patent No 7588915 has been issued by the US Patent and Trademark
Nutri-Force Nutrition has reported the completion of its new manufacturing facility in Miami Lakes, Florida. This new facility was designed from the ground up to provide Nutri-Force’s customers
Natural Alternatives International (NAI) has filed a lawsuit in the US District Court for the District of Delaware, accusing Vital Pharmaceutical (VPX) and DNP International of infringing patents
The Bend Memorial Clinic is enrolling patients for a MAGRIT (MAGE-A3 as Adjuvant Non-Small Cell LunG CanceR ImmunoTherapy) Phase III lung cancer trial aimed at preventing the disease’s
Millennium Laboratories has reported the company’s development and validation of a clinical quantitative assay for the new drug tapentadol (Nucynta) by liquid chromatography/tandem mass spectrometry (LC-MS/MS). In addition,
Quay Pharmaceuticals has announced that it will relocate Wirral to North Wales to new headquarters and manufacturing facility. The transaction is expected to cost £2.7m. Quay Pharmaceuticals’ new
Curtis Packaging was recognised as a green power by EPA, for a new purchase supports clean renewable resources. The company reportedly uses 6 million kilowatt-hours of green power
Dow has announced the launch of low aldehyde grades of Carbowax Sentry PEG. The product is a niche product used to enhance shelf life of formulators. It was
ACADIA Pharmaceuticals reported an increase in revenue to $2.4m for the third quarter of 2009 from $282,000 for the third quarter of 2008. For the nine month ended
Keryx has reported a revenue of $3.5m for the third quarter of 2009, compared to $0.4m for the prior year. For the nine month ended period the company